Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

PASADENA, CA, USA I 10 2025 I Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the global licensing and collaboration agreement ...

but the mechanisms involved vary between different conditions, necessitating distinct therapeutic approaches Friedreich ataxia (FRDA) is caused by deficiency of a mitochondrial protein ...

Evidence for chemotherapy-induced cognitive changes comes from studies that have used neuropsychological testing, imaging (structural and functional magnetic resonance imaging (MRI) and positron ...

Department of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States Biomolecular Science and Engineering Program, University of California ...

"These findings illuminate a critical mechanism that connects local synaptic activity to the broader gene expression changes necessary for learning and memory," said Mark Dell'Acqua, professor of ...

PolyQ SCAs are characterized by degeneration of the cerebellum and its associated structures and lead to progressive ataxia and other diverse symptoms ... The exact pathogenic mechanisms underlying ...

Spinocerebellar ataxia type 3 (SCA3, also known as Machado–Joseph disease ... or sensory feedforward estimation may be related to the underlying mechanism. Hitherto, there are no effective treatments ...